Login
$RNTX
$0.70 +$0.12 (20.75%) Close

Ownership

13F as of Q2 2026 · 86.3M shares outstanding

Who owns RNTX?

By type of holder
Institutions 47.2% Insiders 0.3% Everyone else 52.5%
Concentration Top 10 holders own 37.4%
Voss Capital, LP 6.1% · Cable Car Capital, LP 6.0%
Institutional ownership
47.2%
+34.0 pts vs last qtr
Institutional holders
58
+13 vs last qtr
Net shares bought
+29.3M
by institutions in Q2 2026
New / sold out
21 / 8
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Cable Car Capital, LP +4.8M
  • ADAR1 Capital Management, LLC NEW +4.5M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • ABS Direct Equity Fund LLC SOLD OUT −125.0K
  • Two Sigma Securities, LLC SOLD OUT −31.7K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Rein Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
+460.5%
+77.64% a year
Each share's claim on the business
−82.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $6.61M
over 4 fiscal years
Diluted shares, split-adjusted
13.2M45.2M77.1M2022: 13.6M shares'222023: 13.8M shares'232024: 53.8M shares'242025: 76.3M shares'25
Buybacks Stock-based comp
$0$1.1M$2.2M2022 buybacks: $02022 stock comp: $2.1M'222023 buybacks: $02023 stock comp: $1.2M'232024 buybacks: $02024 stock comp: $1.1M'242025 buybacks: $02025 stock comp: $2.2M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years11% 1–3 years45% Under 1 year44%
Quarterly turnover
131.0%
of institutional shares changed hands
Top 10 managers, median time held
1.5 years

Super Investors

Investment managers reporting RNTX on Form 13F
VC
Voss Capital, LP
Shares
5.3M
% of company
6.10%
Change vs last qtr
+873.6K (+19.9%)
Held since
2024
CC
Cable Car Capital, LP
Shares
5.2M
% of company
6.02%
Change vs last qtr
+4.8M (+1136.9%)
Held since
2024

28 more super investors behind a free account

See every manager holding Rein Therapeutics Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting RNTX on Form N-PORT; together they hold 4.8% of the company
VT
Position value
$2.62M
% of company
2.92%
% of the fund
0.00%
As of
June 30, 2026
VE
Position value
$817K
% of company
0.91%
% of the fund
0.00%
As of
June 30, 2026

9 more funds behind a free account

See every fund holding Rein Therapeutics Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
VR
Von Rickenbach Josef H
Insider
Shares
267.3K
% of company
0.31%
Change vs last qtr
—
Held since
—
WJ
Windsor James Brian
Insider
Shares
22.0K
% of company
0.03%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support